Novel functional PI 3‐kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
New efforts in cancer therapy are being focused at various levels of signaling pathways. With phosphoinositide 3‐kinase (PI3‐K) potentially being necessary for a range of cancer‐related functions, we have investigated the influence of selected inositol tristo hexakisphosphates on cell growth and tumorigenicity. We show that micromolar concentrations of inositol 1,3,4,5,6‐pentakisphosphate and inositol 1,4,5,6‐tetra‐kisphosphate [Ins(1,4,5,6)P 4 ] inhibit IGF‐1‐induced [ 3 H]‐thymidine incorporation in human breast cancer (MCF‐7) cells and the ability to grow in liquid medium and form colonies in agarose semisolid medium by small cell lung cancer (SCLC) cells, a human cancer cell line containing a constitutively active PI3‐K. In an ovarian cancer cell line that also contains a constitutively active PI3‐K (SKOV‐3 cells), Ins(1,4,5,6)P 4 again inhibited liquid medium growth. Furthermore, when applied extracellularly, inositol 1,3,4,5‐tetrakisphosphate was shown indeed to enter SCLC cells. These effects appeared specifically related to PH domains known to bind to phosphatidylinositol 3,4‐bisphosphate [PtdIns(3,4)P 2 ] and phosphatidylinositol 3,4,5‐trisphosphate [PtdIns(3,4,5)P 3 ], indicating involvement of the PI3‐K downstream target protein kinase B (PKB/Akt). This was further supported by inhibition of PKB/Akt PH domain membrane targeting in COS‐7 cells by Ins(1,4,5,6)P 4 . Thus, we propose that specific inositol polyphosphates inhibit PI3‐K by competing with PtdIns(3,4,5)P 3 ‐binding PH domains and that this occurs mainly at the level of the downstream PI3‐K target, PKB/Akt.—Razzini, G., Berrie, C. P., Vignati, S., Broggini, M., Mascetta, G., Brancaccio, A., Falasca, M. Novel functional PI 3‐kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines. FASEB J. 14, 1179–1187 (2000)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specificity and promiscuity in phosphoinositide binding by pleckstrin homology domains
Kavran, J. M., Klein, D. E., Lee, A., Falasca, M., Isakoff, S. J., Skolnik, E. Y., & Lemmon, M. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30497 · Cited by 434 · cited 4×
“Finally, the preferences of the PKB/Akta and PKB/Aktg PH domains appear to be very different (28).”
BackgroundMethodInfluentialSelf-citationIsakoff, S. J., Cardozo, T., Andreev, J., Li, Z., Ferguson, K. M., Abagyan, R., Lemmon, M. A., Aronheim, A., & Skolnik, E. Y. (1998) · The EMBO Journal · doi:10.1093/emboj/17.18.5374 · Cited by 324
Cited by
Akt signalling in health and disease
Hers, I., Vincent, E. E., & Tavaré, J. M. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.05.004 · Cited by 1,239
Sunters, A., Fernández de Mattos, S., Stahl, M., Brosens, J. J., Zoumpoulidou, G., Saunders, C. A., Coffer, P. J., Medema, R. H., Coombes, R. C., & Lam, E. W.-F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309523200 · Cited by 505
Regulating tumor suppressor genes: post-translational modifications
Chen, L., Liu, S., & Tao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0196-9 · Cited by 449
The PTEN, Mdm2, p53 tumor suppressor–oncoprotein network
Mayo, L. D., & Donner, D. B. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02166-7 · Cited by 410
Inositol Polyphosphate Multikinase Is a Physiologic PI3-Kinase That Activates Akt/PKB
Maag, D., Maxwell, M. J., Hardesty, D. A., Boucher, K. L., Choudhari, N., Hanno, A. G., Ma, J. F., Snowman, A. S., Pietropaoli, J. W., Xu, R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017831108 · Cited by 122
Metadata
- Authors
- Razzini, G., Berrie, C. P., Vignati, S., Broggini, M., Mascetta, G., Brancaccio, A., & Falasca, M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2000-06
- Volume
- 14
- Issue
- 9
- Pages
- 1179-1187
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1779463793
- Cited by
- 74
- References
- 2
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel functional PI 3‐kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines. https://app.cochat.ai/papers/10.1096/fasebj.14.9.1179
- The paper
- Razzini, G., Berrie, C. P., Vignati, S., Broggini, M., Mascetta, G., Brancaccio, A., & Falasca, M. (2000). Novel functional PI 3‐kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines. The FASEB Journal. https://doi.org/10.1096/fasebj.14.9.1179
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.